In December 2019, the FDA announced approval of Tandem Diabetes Care Control-IQ™ Technology. Control-IQ Technology on the t:slim X2™ insulin pump can adjust basal insulin delivery…
Read MoreEndocrine Late-Effects of Treatment for Childhood Cancer
Read MoreFiasp (Novo Nordisk) is a faster insulin aspart with an earlier onset of action. In contrast to NovoLog, which is recommended to be dosed within 5-10 minutes before…
Read MoreIn response to findings of a safety signal report that there is reasonable suspicion of a causal association between use of Increlex® and childhood neoplasia, including malignancy,…
Read MoreThe FDA has approved two new ready to use forms of glucagon and these have been introduced to the market: an intranasal powder (Baqsimi, Eli Lilly)…
Read MoreVitamin D is a fat soluble vitamin that is essential for maintaining bone health and also has other potential health benefits. While some of these other…
Read MoreLevothyroxine sodium oral solution (Tirosint-SOL) has now been approved by the FDA and is available for use in the US. Please click on the link below for…
Read MoreAnnually revised Standards of Diabetes Care published by ADA in Diabetes Care.
Read More